The Prostatype® Test System – a new gene test for prostate cancer patients
The Prostatype® Test System is provided in a kit-based format
The test can be run at any molecular pathological laboratory providing short turnover times and full control.
No special expensive equipment required
The Prostatype® Test System is adapted to the qPCR platform LightCycler480 I and II, an instrument available in most molecular pathological laboratories.
No additional sample taking required
PrTS uses the same biopsy material that is currently being used for Gleason Scoring thereby avoiding additional invasive procedures.